Save 20% on Press Releases and More with NNW Prime! Click to View Details
TuesdayJan 31, 2017 1:30 pm

Aytu BioScience, Inc. (AYTU) Starts Presentation at NobleCon13

Aytu BioScience (OTC: AYTU) is a specialty healthcare company that focuses on developing and commercializing novel products in the field of urology in the United States. The company markets Natesto for the treatment of hypogonadism (low testosterone) in men; ProstaScint for use in newly diagnosed high-risk prostate cancer patients and patients with recurrent prostate cancer; and Primsol, an oral solution for urinary tract infections. It is also involved in commercializing of the RedoxSYS System for research use in various applications. In addition, the company is developing MiOXSYS, an in vitro diagnostic semen analysis test that is used in the quantitative…

Continue Reading

TuesdayJan 31, 2017 1:00 pm

Torchlight Energy Resources, Inc. (NASDAQ: TRCH) Starts Presentation at NobleCon13

Torchlight Energy (NASDAQ: TRCH) engages in the acquisition, exploration, exploitation, and/or development of oil and natural gas properties in the United States. It has interests in four oil and gas projects, including the Marcelina Creek Field Development in Wilson County, Texas; the Ring Energy Joint Venture in Southwest Kansas; the Hunton play in Central Oklahoma; and the Orogrande project in Hudspeth County, Texas. It also had interest in a commercial salt water disposal facility in Seminole, Oklahoma. For more information, visit the company’s website torchlightenergy.com About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a…

Continue Reading

TuesdayJan 31, 2017 1:00 pm

NovoCure Ltd. (NASDAQ: NVCR) Starts Presentation at NobleCon13

NovoCure (NASDAQ: NVCR) is a commercial-stage oncology company developing a proprietary therapy called Tumor Treating Fields (TTFields) for the treatment of solid tumor cancers. The company’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed phase 2 pilot trials investigating TTFields in non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.  Headquartered in Jersey, Novocure has operations in Portsmouth, New Hampshire; Malvern, Pennsylvania; and New York City. Additionally, the company has offices in Germany, Switzerland and Japan, and a research center in Haifa, Israel.  For more information, visit the company’s…

Continue Reading

TuesdayJan 31, 2017 1:00 pm

Americas Silver Corp. (USAPF) Starts Presentation at NobleCon13

Americas Silver (OTC: USAPF) is a Canadian-based junior silver producer with assets in the Americas and a strong operating platform. Annual production for 2016 is expected to be 5.0 million-5.6 million silver equivalent ounces. The company has two established producing mines, a third mine in construction, and an advanced stage exploration project. Construction has commenced on the San Rafael project located in Mexico that will increase the company's silver equivalent production to 7.0 million-7.5 million ounces between $7 and $8 silver all in sustaining costs in 2018. For more information, visit the company’s website at www.americassilvercorp.com. About NetworkNewsWire NetworkNewsWire (NNW)…

Continue Reading

TuesdayJan 31, 2017 1:00 pm

BioSpecifics Technologies Corp. (NASDAQ: BSTC) Starts Presentation at NobleCon13

BioSpecifics Technologies (NASDAQ: BSTC) is a biopharmaceutical company that engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren’s contracture and Peyronie’s disease under the XIAFLEX brand in Canada and Australia, as well as under XIAPEX brand name in Europe. It also provides injectable collagenase to treat frozen shoulder, cellulite, canine lipoma, lateral hip fat, and plantar fibromatosis, as well as for the treatment of human lipoma and uterine fibroids. BioSpecifics is also involved in the development of other clinical indications for which collagenase…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Marlin Gold Mining Ltd. (MLNGF) Starts Presentation at NobleCon13

Marlin Gold Mining (OTC: MLNGF) explores for, develops, and produces gold in the Americas. The company also explores for silver ores. It principal project is the Taunus deposit that is held by the La Trinidad property located in Sinaloa, Mexico. The company was formerly known as Oro Mining Ltd. and changed its name to Marlin Gold Mining Ltd. in November 2012. Marlin Gold Mining Ltd. was incorporated in 2000 and is headquartered in Vancouver, Canada. For more information, visit the company’s website at www.marlingold.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Del Mar Pharmaceuticals, Inc. (NASDAQ: DMPI) Starts Presentation at NobleCon13

Del Mar Pharmaceuticals (NASDAQ: DMPI) is a pharmaceutical company that develops and commercializes new cancer therapies in indications where patients are failing or have become intolerable to modern targeted or biologic treatments. The company's lead drug in development, VAL-083, is currently undergoing clinical trials in the U.S. as a potential treatment for refractory glioblastoma multiforme. VAL-083 has been extensively studied by U.S. National Cancer Institute, and is currently approved for the treatment of chronic myelogenous leukemia and lung cancer in China. Published pre-clinical and clinical data suggest that VAL-083 may be active against a range of tumor types via a…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Quest Resource Holding Corp. (NASDAQ: QRHC) Starts Presentation at NobleCon13

Quest Resource Holding (NASDAQ: QRHC) provides management programs to reuse, recycle and dispose various waste streams and recyclables in the United States. The company offers recycling management services for motor oil, oil filters, scrap tires, grease and cooking oil, and expired food products; and various other materials, such as glass, cardboards, paper, metals, plastic oil bottles, hazardous materials, HDPE plastics, construction debris, batteries, mercury, lights, regulated medical waste, electronics, parts cleaners, used absorbents, solid waste, and industrial cleaning products. It also provides landfill diversion services and environmental certification services. For more information, visit the company’s website at www.qrhc.com. About NetworkNewsWire…

Continue Reading

TuesdayJan 31, 2017 12:30 pm

Onconova Therapeutics, Inc. (NASDAQ: ONTX) Starts Presentation at NobleCon13

Onconova Therapeutics (NASDAQ: ONTX) is a phase III stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted anti-cancer agents designed to work against specific cellular pathways that are important in cancer cells, while causing minimal damage to normal cells. Onconova has three product candidates in clinical trials and several active pre-clinical programs. Advanced clinical trials are aimed at unmet medical needs of patients with myelodysplastic syndromes (MDS). For more information, visit the company’s website at www.onconova.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and…

Continue Reading

TuesdayJan 31, 2017 12:00 pm

Interpace Diagnostics Group, Inc. (NASDAQ: IDXG) Starts Presentation at NobleCon13

Interpace Diagnostics Group (NASDAQ: IDXG) develops and commercializes molecular diagnostic tests for physicians and patients to detect genetic and other molecular alterations associated with gastrointestinal and endocrine cancers in the United States. The company offers PancraGen, a diagnostic test designed for determining risk of malignancy in pancreatic cysts; ThyGenX, a sequencing test designed to assist physicians in distinguishing between benign and malignant genotypes in indeterminate thyroid nodules; ThyraMIR, a novel microRNA gene expression classifier; and PathFinder TG Barrett's, an esophageal cancer risk classifier. For more information, visit the company’s website at www.pdi-inc.com. About NetworkNewsWire NetworkNewsWire (NNW) provides news aggregation and…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 512.354.7000